Clinical trials
Neuromuscular Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 6 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fulcrum Therapeutics | 3 |
| PTC Therapeutics | 3 |
| PepGen Inc | 3 |
| The Hospital for Sick Children | 3 |
| Catabasis Pharmaceuticals | 2 |
| Children's Hospital of Eastern Ontario | 2 |
| Ottawa Hospital Research Institute | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| Abcuro, Inc. | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromuscular Diseases | 33 |
| Muscular Dystrophies | 15 |
| Musculoskeletal Diseases | 14 |
| Nervous System Diseases | 12 |
| Muscular Diseases | 10 |
| Muscular Dystrophy, Duchenne | 9 |
| Genetic Diseases, Inborn | 8 |
| Muscular Disorders, Atrophic | 8 |
| Myotonic Dystrophy | 5 |
| Genetic Diseases, X-Linked | 4 |
Trials
Showing 26 to 33 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.